Development
Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.40K | 150.30K | 24.10K | 20.30K | 19.50K |
| Total Receivables | 62.30K | 114.50K | 77.50K | 107.30K | 130.00K |
| Inventory | 140.80K | 122.20K | 132.40K | 115.50K | 223.40K |
| Prepaid Expenses | 100.00K | 23.10K | 55.80K | 44.20K | 91.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.60K | 1.50K | -- | 21.60K | -- |
| Total Current Assets | 447.10K | 411.50K | 289.90K | 308.80K | 464.50K |
|
|
|||||
| Total Current Assets | 447.10K | 411.50K | 289.90K | 308.80K | 464.50K |
| Net Property, Plant & Equipment | 1.02M | 1.14M | 1.24M | 1.34M | 1.56M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.47M | 1.55M | 1.53M | 1.65M | 2.02M |
|
|
|||||
| Total Accounts Payable | 2.59M | 2.44M | 2.23M | 2.04M | 1.56M |
| Total Accrued Expenses | -- | 46.10K | -- | -- | -- |
| Short-term Debt | 620.40K | 688.50K | 946.40K | 1.16M | 1.02M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 137.20K | 222.20K | 208.20K | 246.30K | 242.60K |
| Total Finance Division Other Current Liabilities | -- | -- | 382.50K | 9.80K | 22.00K |
| Total Other Current Liabilities | -- | -- | 382.50K | 9.80K | 22.00K |
| Total Current Liabilities | 3.34M | 3.39M | 3.77M | 3.46M | 2.84M |
|
|
|||||
| Total Current Liabilities | 3.34M | 3.39M | 3.77M | 3.46M | 2.84M |
| Long-Term Debt | 1.47M | 992.30K | 142.70K | 137.40K | 145.40K |
| Short-term Debt | 620.40K | 688.50K | 946.40K | 1.16M | 1.02M |
| Capital Leases | -- | -- | -- | 21.40K | 85.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | -- |
| Total Liabilities | 4.81M | 4.38M | 3.91M | 3.61M | 3.08M |
|
|
|||||
| Common Stock & APIC | 22.23M | 22.16M | 20.19M | 22.04M | 22.08M |
| Retained Earnings | -27.42M | -26.79M | -26.15M | -25.70M | -24.87M |
| Treasury Stock & Other | 1.85M | 1.79M | 3.58M | 1.70M | 1.73M |
| Total Common Equity | -3.34M | -2.84M | -2.38M | -1.96M | -1.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.34M | -2.84M | -2.38M | -1.96M | -1.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.34M | -2.84M | -2.38M | -1.96M | -1.05M |
|
|
|||||